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Cholesterol-Rich Membrane Microdomains Mediate Cell Cycle Arrest Induced by
Actinobacillus Actinomycetemcomitans Cytolethal-Distending Toxin
Abstract
We have previously shown that Actinobacillus actinomycetemcomitans cytolethal-distending toxin (Cdt)
is a potent immunosuppressive agent that induces G2/M arrest in human lymphocytes. In this study, we
explored the possibility that Cdt-mediated immunotoxicity involves lipid membrane microdomains. We
first determined that following treatment of Jurkat cells with Cdt holotoxin all three Cdt subunits localize
to these microdomains. Laser confocal microscopy was employed to colocalize the subunits with
GM1-enriched membrane regions which are characteristic of membrane rafts. Western blot analysis of
isolated lipid rafts also demonstrated the presence of Cdt peptides. Cholesterol depletion, using methyl βcyclodextrin, protected cells from the ability of the Cdt holotoxin to induce G2 arrest. Moreover,
cholesterol depletion reduced the ability of the toxin to associate with Jurkat cells. Thus, lipid raft integrity
is vital to the action of Cdt on host cells. The implications of our observations with respect to Cdt mode of
action are discussed. © 2005 The Authors; Journal compilation © 2005 Blackwell Publishing Ltd.
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Cholesterol-rich membrane microdomains mediate cell
cycle arrest induced by Actinobacillus
actinomycetemcomitans cytolethal-distending toxin
Kathleen Boesze-Battaglia,1* Dave Besack,2
Terry McKay,2 Ali Zekavat,2 Linda Otis,3
Kelly Jordan-Sciutto2 and Bruce J. Shenker2
Departments of 1Biochemistry, 2Pathology and 3Oral
Medicine, University of Pennsylvania School of Dental
Medicine, Philadelphia, PA, USA.
Summary
We have previously shown that Actinobacillus actinomycetemcomitans cytolethal-distending toxin (Cdt) is
a potent immunosuppressive agent that induces G2/
M arrest in human lymphocytes. In this study, we
explored the possibility that Cdt-mediated immunotoxicity involves lipid membrane microdomains. We
first determined that following treatment of Jurkat
cells with Cdt holotoxin all three Cdt subunits localize
to these microdomains. Laser confocal microscopy
was employed to colocalize the subunits with GM1enriched membrane regions which are characteristic
of membrane rafts. Western blot analysis of isolated
lipid rafts also demonstrated the presence of Cdt peptides. Cholesterol depletion, using methyl b-cyclodextrin, protected cells from the ability of the Cdt
holotoxin to induce G2 arrest. Moreover, cholesterol
depletion reduced the ability of the toxin to associate
with Jurkat cells. Thus, lipid raft integrity is vital to the
action of Cdt on host cells. The implications of our
observations with respect to Cdt mode of action are
discussed.
Introduction
The cytolethal-distending toxins (Cdts) are a family of
heat-labile protein cytotoxins produced by several different
bacterial species including diarrhoeal disease-causing
enteropathogens such as Escherichia coli, Campylobacter jejuni, Shigella species, Haemophilus ducreyi, Salmonella typi and Actinobacillus actinomycetemcomitans
(Pickett et al., 1994; Scott and Kaper, 1994; Okuda et al.,
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1995; 1997; Comayras et al., 1997; Mayer et al., 1999;
Pickett and Whitehouse, 1999; Shenker et al., 2000;
Haghjoo and Galan, 2004). We have previously shown
that the Cdt derived from A. actinomycetemcomitans is a
potent immunotoxin capable of inducing G2 arrest and
ultimately apoptosis in human lymphocytes (Gelfanova
et al., 1999; Shenker et al., 1999; 2001; Nalbant et al.,
2003). There is now clear evidence that Cdt is encoded
by three genes, designated cdtA, cdtB and cdtC, which
encode polypeptides with apparent molecular masses of
approximately 24–35 kDa (Lara-Tejero and Galan, 2001;
Mao and DiRienzo, 2002; Deng and Hansen, 2003; Shenker et al., 2004). Moreover, we have recently demonstrated that the Cdt holotoxin consists of each of the Cdt
subunits: CdtA, CdtB and CdtC. The Cdt holotoxin
appears to function as an AB2 toxin where CdtB is the
active (A) unit and the complex of CdtA and CdtC comprise the binding (B) unit (Elwell and Dreyfus, 2000; LaraTejero and Galan, 2001; Nesic et al., 2004). Furthermore,
it is generally agreed that the active subunit, CdtB, enters
the cell while CdtA and CdtC remain associated with the
cell surface (Cortes-Bratti et al., 2000; McSweeney and
Dreyfus, 2004; Nesic et al., 2004).
It is well documented that plasma membranes consist
of microscopically and biochemically distinguishable lipid
microdomains. Membrane bilayer organization into these
microdomains known, colloquially as membrane rafts and
super-rafts, provides the requisite temporal and spatial
organization of protein and lipid components necessary
for normal cellular function (Simons and Ikonen, 1997;
Brown and London, 1998; Zajchowski and Robbins, 2002;
Horejsi, 2004; Pike, 2004). A unique property of these
membrane rafts is their resistance to solubilization at low
temperatures by mild detergents such as Triton X-100,
NP-40 and Brij; this insolubility is due, in part, to long
saturated acyl chains of gangliosides that impart a high
degree of order and also by stabilization of intercalating
cholesterol molecules (Simons and Ikonen, 1997; Brown
and London, 1998). In addition to their unique lipid profile,
membrane rafts also contain a number of extracellular and
cytoplasmic proteins involved in signal transduction. The
organization of rafts restricts access so that only limited
proteins can reside in rafts; these include those attached
to the membrane by a lipid anchor, such as glycosylphos-
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phatidylinoisitol (GPI)-anchored proteins, acylated cytosolic proteins and certain transmembrane proteins (Simons
and Ikonen, 1997; Brown and London, 1998; Horejsi,
2004). Membrane rafts are involved in cellular processes
as diverse as fertilization, viral infection, maintenance of
cell polarity, chemotaxis, apoptosis and development
(Simons and Ikonen, 1997; Brown and London, 1998; van
der Goot and Harder, 2001; Zajchowski and Robbins,
2002; Horejsi, 2003; 2004). Thus, it has been proposed
that rafts may play a pivotal role in the plasma membrane
by serving as platforms that co-ordinate the induction of
signalling pathways. Indeed, lipid rafts isolated from lymphocytes not only contain Src kinases but these membrane complexes also have been implicated in regulating
cell activation following engagement of the T-cell receptor
(TCR) as well as interleukin-2 receptor signalling (Xavier
et al., 1998; Alonso and Millan, 2001; Marmor and Julius,
2001).
In addition to a role in cell signalling, it has become
increasingly evident that several pathogens and microbialderived toxins interact with their target cell via membrane
rafts (van der Goot and Harder, 2001). For instance, rafts
may provide a mechanism by which receptors are concentrated and thereby promote binding. One such example is cholera toxin which is pentameric and binds to
targets cells via the ganglioside GM1. It is likely that cholera toxin simultaneously binds with high affinity to multiple
receptors as result of receptor concentration within the
lipid microdomain (Montecucco et al., 1994; van der Goot
and Harder, 2001). Likewise, pore-forming toxins such as
Aeromonas hydrophila, which binds to GPI-anchored proteins, utilize the concentrating properties of lipid rafts to
facilitate oligomerization, a requisite for channel formation
(Abrami and van der Goot, 1999; van der Goot and
Harder, 2001). Membrane rafts may also facilitate signalling following the binding of bacterial toxins to raftassociated receptors. In this regard, bacterial lipopolysaccharride (LPS) interacts with rafts via CD14, a GPIanchored receptor; LPS binding results in mitogenactivated protein (MAP) kinase activation and eventually
cytokine production. Finally, membrane rafts may serve
as entry sites for pathogens; in this regard several pathogens enter host cells in a cholesterol-dependent manner
(van der Goot and Harder, 2001; Lencer, 2001). Furthermore, the uptake of E. coli strains which express FimH
have been shown to involve cholesterol-rich microdomains. Similarly, Shigella invades cells via interaction
between the invasin, IpaB, and the raft-associated receptor, CD44. Viruses such as SV40 also utilize rafts either
for internalization or as a site for fusion with the plasma
membrane (Lafont et al., 2002).
It is clear that lipid microdomains play a pivotal role in
regulating T-cell activation and function. Moreover, there
is growing evidence that several microbes specifically tar-

get raft domains in order to infect host cells and/or hijack
these signalling platforms to promote pathogenic events.
Therefore, we explored the possibility that Cdt-mediated
immunotoxicity is cholesterol dependent. We now report
that Cdt colocalizes to membrane rafts. The association
of all three Cdt subunits with lipid rafts was evident from
Western blot analysis of isolated raft fractions and confocal microscopy of toxin-treated cells. Cholesterol depletion
of Jurkat cell membranes confers resistance to Cdtinduced G2 arrest indicating that the integrity of cholesterol-rich microdomains is crucial to toxin activity. Finally,
cholesterol-depleted cells exhibited reduced ability to bind
Cdt. These studies clearly indicate that lipid rafts are
indeed critical to the mechanism by which Cdt induces cell
cycle arrest in target cells.
Results
The Cdt holotoxin is composed of three truncated subunits: CdtA, CdtB and CdtC, and furthermore, a complex
of CdtA and CdtC is required for interaction of the toxin
with target cell membranes leading to toxin-induced G2
arrest. Moreover, following a 2 h exposure to Cdt holotoxin, the individual subunits could be detected associated
with Jurkat cell membranes. We therefore wanted to determine whether any of the Cdt subunits associate with membrane lipid microdomains. In order to conduct these
experiments, we first needed antibodies capable of recognizing the individual Cdt subunits when they are present
in the holotoxin complex and associated with cells. Monoclonal antibodies (mAbs) were generated and characterized in terms of their peptide specificity by both Western
blot analysis and enzyme-linked immunosorbent assay
(ELISA) as well as for their ability to recognize the peptide
in association with the holotoxin complex by surface plasmon resonance (data not sown). Figure 1 shows flow
cytometric analysis of Jurkat cells after they have been
treated with the Cdt holotoxin and then stained using three
of these mAbs. The mAbs specifically recognize either
CdtA (Fig. 1A), CdtB (Fig. 1B) or CdtC (Fig. 1C) when the
toxin is associated with cells. These mAbs were used in
this study to investigate the localization of Cdt subunits to
membrane lipid microdomains.
To demonstrate that the Cdt subunits not only associate
with the cell membrane, but localize to lipid rafts, Jurkat
cells were treated with the holotoxin and then dual stained
to identify individual Cdt peptides and GM1, a well-established marker for membrane rafts. Cells were first exposed
to cholera toxin B unit (CTB)-AlexaFluor 647 to identify
GM1 and patches representing microdomains were
induced by treatment with anti-CTB antisera (Figs 2B, E
and H, 3B, E and H, 4B, E and H). Cells were then
exposed to Cdt holotoxin for 2 h, washed and stained with
mAb to either CdtA, CdtB or CdtC (Figs 2D and G, 3D

© 2005 The Authors
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Fig. 1. Detection of Cdt subunits associated with the Jurkat cell surface following treatment with Cdt holotoxin. Jurkat cells were exposed
to Cdt holotoxin (2 µg ml−1) for 2 h and then treated with control
murine IgG (dotted lines), anti-CdtA mAb [solid line in (A); mAb
Cdt162]; anti-CdtB mAb [solid line in (B); mAb Cdt171] or anti-CdtC
mAb [solid line in (C); mAb Cdt112]. Cells were then sequentially
stained with goat anti-mouse Ig conjugated to biotin and streptavidin
conjugated to FITC and analysed by flow cytometry. FITC fluorescence is plotted versus relative cell number. Numbers represent the
mean channel fluorescence (MCF); at least 10 000 cells were analysed per sample. Results are representative of three experiments.

and G, 4D and G). To control for non-specific staining with
the anti-Cdt mAbs, isotype-matched control IgG was used
instead (Figs 2A, 3A and 4A). Analysis of merged images
indicates that both CdtA (Fig. 2F and I) and CdtC (Fig. 4F
and I) colocalize with GM1 (CTB fluorescence); virtually
all CdtA (> 96%) and CdtC (> 88%) fluorescence is found
associated with the GM1 patches. In contrast, most, but
not all, of CdtB fluorescence exhibited colocalization to
GM1 (Fig. 3F and I). Analysis of the fluorescence distribution indicates that only 70% of anti-CdtB fluorescence
is associated with GM1. While CdtB is known to enter
cells, it should be noted that these experiments only
assessed Cdt subunits associated with the cell surface;
immunofluorescent staining was performed before permeabilization for DAPI staining. Wheat germ agglutinin was
also employed to verify that the toxin did not alter cell
permeability; no difference was noted in the immunofluorescent pattern for wheat germ agglutinin in control cells
versus Cdt holotoxin-treated cells (data not shown).
Further support for localization of Cdt peptides to
cholesterol-rich microdomains was obtained by isolating detergent-resistant membranes (DRMs) from both
untreated (no toxin) Jurkat cells and cells exposed to Cdt
holotoxin. Following a 2 h incubation, Jurkat cells were
disrupted, homogenized in ice-cold Triton X-100 and ultracentrifuged on a sucrose gradient. Two distinct low-buoyant-density bands, designated DRM1 and DRM2, were
obtained (Fig. 5). The lipid and protein composition of
these bands was analysed to verify that they were indeed
rafts. As shown in Fig. 5, both DRM1 and DRM2 were
enriched in GM1 (dot blot) and in total cholesterol. Scanning densitometric analysis of the blots indicated that
GM1 was approximately equal in DRM1 and DRM2 from
both control and toxin-treated cells. DRM1 isolated from
toxin treated cells had a cholesterol/phosphate ratio of
0.18; in contrast, the Triton X-100 soluble fraction had a
ratio of 0.08. Similarly, DRM1 from untreated cells had a
cholesterol/phosphate ratio of 0.14 and the ratio of the
soluble fraction was 0.08. Moreover, the raft-associated
protein, Lck, was enriched in these fractions as well. In
contrast, the transferrin receptor (CD71), a non-raftassociated protein, was found only in the soluble fraction.
The DRMs were also analysed to determine the relative
distribution of toxin subunits (Fig. 6). Following treatment
of Jurkat cells with Cdt holotoxin, the DRMs were isolated
and analysed by Western blot. All three subunits were
found associated with DRM1; >95% of CdtA and CdtC
were associated with this fraction. In contrast, 80% of
CdtB was present in DRM1 and a significant amount of
peptide was also observed in DRM2 (15.8%) as well as
in the soluble fraction (3.5%). It should be noted that the
amount of CdtB present in the soluble fraction was probably greater than 3.5% when total sample volume is taken
into account. CdtA and CdtC were minimally detected in

© 2005 The Authors
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Fig. 2. Colocalization of CdtA with GM1. Jurkat cells were treated with CTB conjugated to AlexaFluor 647 and patched with anti-CTB sera. The
cells were then treated with Cdt holotoxin and stained with control IgG (A–C) or anti-CdtA (mAb162; D–I) as described in Experimental procedures
and assessed using laser confocal microscopy. Images of FITC fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are
shown as well as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red) fluorescence along with DAPI-stained nuclei;
colocalization is shown in yellow. Analysis of the images indicate that > 96% of CdtA fluorescence colocalizes with CTB fluorescence. Results
are representative of three experiments.

DRM2, 1.6% and 5.4%, respectively; neither of these subunits were found in the soluble fraction. Moreover, both
CdtA and CdtC were found to be required for toxin localization to membrane lipid rafts. CdtB was not detected in
DRMs when cells were exposed to this subunit alone. In
contrast, both CdtA and CdtC were able to localize to
DRM1 (> 98%) when Jurkat cells were treated with only
these two subunits. These results were not surprising as
the CdtA and CdtC subunits have been shown to be
required for association of the holotoxin with cells.
In these studies we observed that the relative buoyancy
of the DRM fractions differed upon toxin treatment; DRMs
from toxin treated cells routinely floated at 13% (DRM1)
and 22% (DRM2) sucrose while DRMs from untreated
cells floated at 15% (DRM1) and 20% (DRM2) sucrose.

The change in the banding pattern of the DRMs prompted
us to further assess the lipid composition of membrane
rafts from control and toxin-treated cells. As shown in
Table 1, there was no significant difference between the
major classes of phospholipids in control DRMs versus
that of DRMs isolated from Cdt-treated cells. Also, the
phospholipid content of DRM1 and DRM2 were similar.
To determine whether Cdt action is dependent on membrane microdomains, we assessed whether the integrity
of these cholesterol enriched rafts was critical to Cdtinduced cell cycle arrest. Jurkat cell membranes were
depleted of cholesterol with 0–10 mM methyl β-cyclodextrin (MβCD). After 30 min exposure, cells were washed,
incubated for 18 h in the presence of Cdt holotoxin
(40 pg ml−1) and analysed for cell cycle distribution. Jurkat

© 2005 The Authors
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Fig. 3. Colocalization of CdtB with GM1. Jurkat cells were treated with CTB conjugated to AlexaFluor 647 and patched with anti-CTB sera. The
cells were then treated with Cdt holotoxin and stained with control IgG (A–C) or anti-CdtB (mAb171; D–I) as described in Experimental procedures
and assessed using laser confocal microscopy. Images of FITC fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are
shown as well as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red) fluorescence along with DAPI-stained nuclei;
colocalization is shown in yellow. Analysis of the images indicates that 70% of CdtB fluorescence colocalizes with CTB fluorescence. Results are
representative of three experiments.

Table 1. Lipid content of Jurkat DRMs (mole%).a
DRM1

DRM2

Lipid

Control

Cdt-treated

Control

Cdt-treated

SM
PC
PS
PI
PE
PG
Lyso-PG
PA

10.5 ± 2.3
54.3 ± 4.0
7.7 ± 1.7
6.2 ± 0.6
20.8 ± 2.6
0.2 ± 0.3
2.7 ± 0.2
5.0 ± 5.0

8.2 ± 1.2
53.8 ± 5.7
7.5 ± 2.5
5.2 ± 2.0
23.4 ± 1.3
0.2 ± 0.3
1.6 ± 1.6
0.7 ± 0.7

11.8 ± 6.2
39.7 ± 10.7
11.0 ± 5.3
6.1 ± 2.1
22.8 ± 5.0
ND
0.7 ± 0.1
ND

9.7 ± 5.3
42.5 ± 7.3
7.4 ± 0.5
4.0 ± 1.3
30.2 ± 13.2
ND
ND
ND

a. Results are mean ± SEM of three experiments each performed in
duplicate.
SM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; PE, phosphatidylethanolamine;
PG, phosphatidylglycerol; PA, phosphatidic acid; ND, not detected.

cells exposed to only Cdt holotoxin exhibited 60% G2 cells
(Fig. 7A); this compares with 15% G2 cells in untreated
controls (data not shown). Pre-treatment of Jurkat cells
with 2.5–10 mM MβCD resulted in a dose-dependent
reduction in Cdt holotoxin-induced G2 accumulation:
46.9% G2/M (2.5 mM; Fig. 7B), 32.3% G2/M (5.0 mM;
Fig. 7C) and 27.1% G2/M (10 mM; Fig. 7D). As reported
by others, no cytotoxic effects of MβCD were noted at
these concentrations (Nguyen and Taub, 2002; Pizzo
et al., 2002; Rajendran et al., 2003). To control for MβCD
effects unrelated to cholesterol depletion, Jurkat cells
were also pre-treated with cholesterol-saturated MβCD.
Cells were treated as described above with medium,
10 mM MβCD or 10 mM cholesterol-saturated MβCD,
washed and then incubated for 18 h in the presence of
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Fig. 4. Colocalization of CdtC with GM1. Jurkat cells were treated with CTB conjugated to AlexaFluor 647 and patched with anti-CTB sera. The
cells were then treated with Cdt holotoxin and stained with control IgG (A–C) or anti-CdtC (mAb112; D–I) as described in Experimental procedures
and assessed using laser confocal microscopy. Images of FITC fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are
shown as well as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red) fluorescence along with DAPI-stained nuclei;
colocalization is shown in yellow. Analysis of the images indicates that >88% of CdtC fluorescence colocalizes with CTB fluorescence. Results
are representative of three experiments.

Cdt holotoxin. Jurkat cells exposed to medium only exhibited 15.2% G2/M cells (Fig. 8A) while cells exposed to
toxin alone exhibited more than threefold increase in the
percentage of G2/M cells (49.3%; Fig. 8B). As shown in
Fig. 8C, cells first treated with 10 mM MβCD and then
exposed to Cdt holotoxin exhibited only a slight increase
in G2/M cells (25%); this compares with 49% G2 cells
when Jurkat cells were pre-treated with cholesterolsaturated MβCD (Fig. 8D).
In another series of experiments, we observed that cholesterol reconstitution of MβCD-treated cells restores susceptibility to Cdt holotoxin. As shown in Fig. 9, pretreatment of Jurkat cells with MβCD reduced cell susceptibility to Cdt-induced G2/M arrest. Control cells contained
13.4% G2/M cells (Fig. 9A); the percentage of cells in the

G2/M phase increased in Cdt holotoxin-treated cells
(62.9%; Fig. 9B) and cells pre-exposed to MβCD and then
treated with Cdt holotoxin exhibited 30.2% G2/M
(Fig. 9D). Cholesterol repletion of MβCD-treated cells with
cholesterol-saturated MβCD restored susceptibility of Jurkat cells to Cdt holotoxin; these cells contained 57.3% G2/
M (Fig. 9F). It should also be noted that Jurkat cells were
not adversely affected by these agents; cell cycle profiles
of cells treated with either MβCD (Fig. 9C) or MβCD plus
cholesterol-saturated MβCD (Fig. 9E) in the absence of
toxin were similar to control cells (Fig. 9A). Thus, it
appears that intact membrane rafts are critical to the
action of Cdt in lymphocytes.
In a final series of experiments, we assessed whether
cholesterol depletion also altered the ability of the toxin to

© 2005 The Authors
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MCF was reduced for all three subunits: anti-CdtA (9.0;
Fig. 10D), anti-CdtB (13.0; Fig. 10F) and anti-CdtC (10.2;
Fig. 10G).

% Total Cholesterol

Discussion

Sucrose Gradient Fractions
Fig. 5. Isolation of Jurkat cell DRMs. Jurkat cells were treated with
Cdt holotoxin for 2 h and DRMs were isolated as described in Experimental procedures. Two distinct low-buoyant-density bands, designated DRM1 and DRM2, were obtained. The composition of these
bands was analysed to ascertain that they were indeed lipid rafts.
DRM1, DRM2 and the soluble fraction were assessed for cholesterol
(bottom) and GM1 (dot blot). The protein profile of the fractions was
assessed by Western blot analysis for the presence of the raft-associated protein, Lck, which was enriched in these fractions. In contrast,
the transferrin receptor (CD71), a non-raft-associated protein, was
found in the soluble fraction. Results are representative of three
experiments.

associate with cells. Jurkat cells were pre-treated with
10 mM MβCD for 30 min, exposed to Cdt holotoxin for 1 h
and then the cells were analysed by flow cytometry for the
presence of toxin subunits on the surface following staining with anti-Cdt mAb. As shown in Fig. 10, all three Cdt
subunits could be detected on cells pre-incubated in
medium alone; mean channel fluorescence (MCF) was
34.9, 20.4 and 17.8 for anti-CdtA (Fig. 10C), anti-CdtB
(Fig. 10E) and anti-CdtC (Fig. 10G) respectively. Pretreatment of cells with MβCD reduced toxin binding; the

In this study, we provide evidence that Cdt preferentially
associates with cholesterol-rich membrane rafts. The
association of Cdt subunits with lipid rafts was corroborated utilizing two independent approaches. It is well
established that lipid rafts are enriched in glycosphingolipids, including the ganglioside GM1. GM1 can be detected
within lipid microdomains with CTB, the membrane-binding cholera toxin subunit. Once bound to GM1, CTB is
readily observed microscopically following patch formation induced by exposing cells to anti-CTB. Utilizing this
approach, we were able to demonstrate colocalization of
all three Cdt subunits with CTB bound to GM1. It is noteworthy that essentially all of the CdtA subunit and most of
the CdtC subunit co-patched with GM1. In contrast,
approximately 30% of CdtB was not associated with GM1.
In addition to microscopic colocalization, we also
employed a biochemical approach to ascertain that Cdt
peptides associate with membrane rafts. Following treatment of Jurkat cells with Cdt holotoxin, detergent-resistant
cholesterol rich microdomains were isolated and
assessed by Western blot for the presence of toxin subunits. All three subunits were found within the isolated
rafts. Both CdtA and CdtC were restricted to the raft,
whereas a portion of CdtB was also observed to be in the
soluble fraction. The Western blot is consistent with the
notion that CdtB enters the cell and that the other two
subunits most likely remain membrane associated. These
findings are consistent with observations made by several
laboratories suggesting that CdtB, the active Cdt subunit,
must enter the cell to induce cell cycle arrest (Shenker
et al., 1999; 2004; Cortes-Bratti et al., 2000; Lara-Tejero
and Galan, 2000; McSweeney and Dreyfus, 2004; Guerra
et al., 2005). Moreover, our studies clearly demonstrate
that CdtA and CdtC are required for localization to these
membrane micodomains; these results are consistent
Fig. 6. Western blot analysis of Cdt peptides
associated with DRMs. Jurkat cells were
treated with Cdt holotoxin, CdtB peptide or both
CdtA and CdtC for 2 h; DRMs were isolated as
described in Experimental procedures. DRM1,
DRM2 and the soluble fraction were analysed
for the presence of each Cdt peptide by Western blot analysis using mAb specific for CdtA,
CdtB and CdtC. The immunoblots were analysed by digitized scanning densitometry; the
numbers represent the relative distribution (%)
of each subunit within DRM1, DRM2 and the
soluble (s) fractions respectively. Results are
representative of three experiments.
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Fig. 7. Effect of MβCD on Cdt-induced cell
cycle arrest. Jurkat cells were pre-treated with
medium (A), 2.5 mM (B), 5.0 mM (C) or 10 mM
(D) MβCD for 30 min. The cells were washed,
exposed to Cdt holotoxin (40 pg ml−1), incubated for 18 h, stained with propidium iodide
and analysed for cell cycle distribution by flow
cytometry. Cell cycle distribution is based on
DNA content (propidium iodide fluorescence)
which is plotted versus relative cell number. G0/
G1 cells are found in the first peak (MCF of 75)
and G2/M cells in the second peak (MCF of
150); the percentage of cells in S phase was
determined based on computer modelling as
noted in Experimental procedures. Numbers
represent the percentage of cells in the G0/G1,
S and G2/M phases of the cell cycle. Results
are representative of four experiments; 15 000
cells were analysed for each sample. Parallel
experiments verified that MβCD did not
adversely affect Jurkat cell viability as determined by propidium iodide exclusion.

with the notion that CdtA and CdtC represent the binding
components of the holotoxin.
The microscopic and biochemical analyses provide
strong support that the Cdt subunits associate with lipid
rafts. However, these data do not provide information as

to whether the microdomains actually participate in the
sequence of toxin-induced events leading to cell cycle
arrest. A frequently employed approach to address this
possibility consists of disrupting rafts by extracting cholesterol with sequestering agents, such as MβCD. This drug

Fig. 8. Effect of MβCD and cholesterol-saturated MβCD on Cdt-induced cell cycle arrest.
Jurkat cells were pre-treated with medium (A
and B), 10 mM MβCD (C) or cholesterol-saturated MβCD (D) for 30 min, washed, exposed
to Cdt holotoxin (40 pg ml−1; B–D), incubated
for 18 h, stained with propidium iodide and
analysed for cell cycle distribution by flow
cytometry as described. Numbers represent
the percentage of cells in the G0/G1, S and G2/
M phases of the cell cycle. Results are representative of four experiments; 15 000 cells were
analysed for each sample.
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Fig. 9. Cholesterol repletion in MβCD-treated
cells restores susceptibility to Cdt. Jurkat cells
were first exposed to medium (A and B) or
5 mM MβCD (C–F) for 30 min. The cells were
washed and incubated for 30 min in the presence of medium (A–D) or cholesterol-saturated
MβCD (E and F; 0.5 mM). Cells were then incubated for 18 h in the presence of medium (A, C
and E) or Cdt holotoxin (40 pg ml−1; B, D and
F), stained with propidium iodide and analysed
for cell cycle distribution by flow cytometry.
Numbers represent the percentage of cells in
the G0/G1, S and G2/M phases of the cell
cycle. Results are representative of three
experiments; 15 000 cells were analysed for
each sample.

is efficient in extracting membrane cholesterol resulting in
dispersal of the rafts into the plasma membrane; as a
consequence the rafts are not only disrupted but also lose
their detergent-resistant properties. Thus, Jurkat cells
were pre-treated with 2.5–10 mM MβCD for 30 min,
exposed to Cdt and then the cells were monitored for cell
cycle progression. Cells treated with MβCD were clearly
resistant to Cdt-induced G2 arrest. These effects were
dependent on the dose of MβCD employed. MβCD has
been shown to have a number of other effects on cells
besides depletion of cholesterol; these include plasma
membrane depolarization and inhibition of calcium mobilization among others (Pizzo and Viola, 2003). To control
for these effects, we also employed cholesterol-saturated
MβCD which is not able to extract cholesterol but retains
the capacity to induce these other effects. Indeed, cholesterol-saturated MβCD failed to inhibit Cdt-induced G2
arrest. In other experiments, cholesterol reconstitution of

MβCD depleted cells restored susceptibility to Cdt indicating that MβCD was not toxic under these conditions.
Collectively, these results clearly demonstrate that the
integrity of membrane lipid rafts is crucial to the action of
Cdt.
An unanticipated effect of Cdt treatment was that the
relative buoyancy of the DRMs from toxin-treated cells
changed suggesting that the lipid composition of membrane rafts had been altered. Therefore, we analysed the
lipid content of both DRM 1 and DRM2. Cdt treatment did
not induce any significant change in content of the major
classes of phospholipid in either DRM1 or DRM2. It is
possible that the change in DRM buoyance is the result
of altered protein content; this possibility is the focus of
ongoing studies.
We have previously shown that the CdtA and CdtC
subunits are responsible for the ability of the Cdt holotoxin
to interact with the cell surface. Furthermore, analysis of

© 2005 The Authors
Journal compilation © 2005 Blackwell Publishing Ltd, Cellular Microbiology, 8, 823–836

14625822, 2006, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1462-5822.2005.00669.x by University Of Pennsylvania, Wiley Online Library on [07/11/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Cytolethal-distending toxin requires cholesterol 831

Fig. 10. Effect of cholesterol depletion on Cdt
binding to Jurkat cells. Jurkat cells were pretreated with medium (A, C, E and G) or 10 mM
MβCD (B, D, F and H) for 30 min. The cells
were washed and treated with Cdt for 1 h. Jurkat cells were then washed and stained with
control IgG (A and B), anti-CdtA mAb (mAb162;
C and D), anti-CdtB mAb (mAb171; E and F)
or anti-CdtC mAb (mAb112; G and H); cells
were then exposed to goat anti-mouse IgG conjugated to FITC as described in Experimental
procedures. Cells were analysed by flow cytometry for FITC fluorescence; numbers in each
panel represent the MCF. Results are representative of three experiments; at least 15 000 cells
were analysed per sample.

the crystal structure of the holotoxin suggests that CdtA
and CdtC together contribute towards the formation of two
notable surface elements; these include an aromatic cluster and a deep groove both of which may be critical to the
interaction of Cdt with the cell surface (Nesic et al., 2004).
Indeed, mutagenesis studies suggest that these structures are vital for toxin activity. To date, no definitive receptor has been identified for Cdt although recent evidence
suggests that carbohydrate residues might be important
(McSweeney and Dreyfus, 2005). However, our studies do
indicate that these membrane microdomains must be
intact not only for Cdt to intoxicate cells, but also to associate with cells as well. In conclusion, we demonstrate that

the Cdt holotoxin interacts with lipid rafts and that the
integrity of these microdomains is vital to both the binding
and action of the toxin. This association between Cdt
subunits and lipid rafts significantly advances our understanding of how the holotoxin interacts with host cells and
raises several possibilities. Lipid microdomains have been
shown to serve as a site of attachment for pathogens and
provide a means to concentrate receptors for toxins and
thereby increase binding affinity. These microdomains
also play a key role in triggering internalization and may
provide a means of entry for the CdtB subunit leading to
retrograde transport through the trans-golgi network.
Finally, rafts may also serve as signalling platforms; this
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raises the possibility that a component of the mechanism
of Cdt action may indeed involve signal transduction.
Studies are currently in progress to further define the role
of lipid rafts in action of this toxin.

pidium iodide fluorescence was excited by an argon laser operating at 488 nm and fluorescence measured with a 630/22 nm
bandpass filter using linear amplification. A minimum of 15 000
events were collected on each sample; cell cycle analysis was
performed using Modfit (Verity Software House, Topsham, ME).

Experimental procedures

Isolation of Triton X-100-resistant membrane rafts

Preparation of Cdt holotoxin and Cdt peptides

Triton X-100-resistant membrane rafts were prepared from the Tcell leukaemia cell line Jurkat (E6-1); the cells (2.0 × 106 cells
ml−1) were incubated in T-75 flasks in the presence of medium or
Cdt holotoxin for 2 h. Following the incubation period, cells were
washed in MOPS buffer and detergent-resistant fractions were
isolated as previously described (Boesze-Battaglia et al., 2002).
Briefly, the cell pellet (4–5 × 108 cells) was resuspended in 1.0 ml
of MOPS buffer; Triton X-100 (2% w/v) was added to a final
concentration of 1% Triton X-100. To distinguish between Triton
X-100-resistant membranes and simply a partial detergentdependent non-raft-specific solubilization, control cells were
homogenized in 1% OG (final) in parallel with the Triton X-100treated samples. Both Triton X-100- and OG-treated samples
were homogenized with three passes of a glass pestle through
a glass Tenboeck tissue grinder. Sucrose was added to the
homogenate (final concentration of 0.9 M) and overlayed with
1.0 ml of 0.8, 0.70, 0.65, 0.60, 0.55 and 0.50 M sucrose. The
homogenates were centrifuged at 40 000 r.p.m. for 20 h at 4°C.
Two prominent bands were recovered, designated DRM1 and
DRM2; these were washed and resuspended in 0.2 ml of Hepes
buffer.

Recombinant Cdt holotoxin was used for most of the experiments
described in this study. Construction and characterization of the
plasmid pUCAacdtABChis which expresses the Cdt holotoxin containing a His tag on the CdtC peptide has previously been
reported (Shenker et al., 2004). The plasmid was constructed so
that the cdt genes were under control of the lac promoter; all
ligation mixtures were transformed into E. coli DH5α. Cultures of
transformed E. coli were grown in 1 l of LB broth and induced
with 0.1 mM IPTG for 2 h; bacterial cells were harvested, washed
and resuspended in 50 mM Tris (pH 8.0). The cells were frozen
overnight, thawed and sonicated. The His-tagged holotoxin was
isolated by nickel affinity chromatograpy as previously described
(Shenker et al., 2000). Briefly, the sonicated bacterial extracts
were applied to a histidine-binding column (HiTrap Chelating HP;
Amersham Biosciences, Uppsala, Sweden). The column was
washed and His-tagged proteins were eluted with 500 mM imidazole; previous studies have demonstrated that the isolated
holotoxin, designated CdtABC, consists of a heterotrimeric complex of CdtA, CdtB and CdtC (Shenker et al., 2004).
Individual Cdt peptides were expressed using an in vitro
expression system; construction of the plasmids pGEMCdtA,
pGEMCdtB and pGEMCdtC was previously described (Shenker
et al., 2005). We employed the Rapid Translation System to
express recombinant peptides (RTS 500 ProteoMaster; Roche
Applied Science); reactions were run according to the manufacturer’s specification (Roche Applied Science) using 10–15 µg of
template DNA. After 20 h at 30°C, the reaction mix was removed
and the expressed Cdt peptides were purified by nickel affinity
chromatography as previously described.

Cell culture and analysis of cell cycle
The T cell leukaemia cell line Jurkat (E6-1; American Type Tissue
Culture Collection, Manassas, VA) was maintained as previously
described (Shenker et al., 2004). Briefly, cells were maintained
in RPMI 1640 supplemented with 10% FCS, 2 mM glutamine,
10 mM Hepes, 100 U ml−1 penicillin and 100 µg ml−1 streptomycin. Cells were harvested in mid-log growth phase and plated at
5 × 105 cells ml−1 in 24-well tissue culture plates or as described
below. The cells were exposed to medium, 2.5–10 mM MβCD
(Sigma Chemical, St Louis, MO) or 10 mM cholesterol-saturated
MβCD; 0.5 mM cholesterol-saturated MβCD was employed for
repletion experiments. Cholesterol-saturated MβCD was prepared as described by Christian et al. (1997). Following a 30 min
incubation, cells were treated with Cdt holotoxin or medium (control) and incubated for 18 h. To measure Cdt-induced cell cycle
arrest, Jurkat cells were washed and fixed for 60 min with cold
80% ethanol. After washing, the cells were stained with 10 µg
ml−1 propidium iodide containing 1 mg ml−1 RNase (Sigma Chemical) for 30 min. Samples were analysed on a Becton–Dickinson
FacstarPLUS flow cytometer (BD Biosciences, San Jose, CA). Pro-

Western blot and GM1 analyses
Samples (20 µl) were separated on 12% SDS-PAGE and then
transferred to nitrocellulose. The membrane was blocked with
BLOTTO and then incubated with one of the following primary
antibodies for 18 h at 4°C (Shenker et al., 1999): anti-CdtA mAb
(CdtA21), anti-CdtB mAb (CdtB194), anti-CdtC mAb (CdtC63),
anti-CD71 mAb (Santa Cruz Biotechnology, Santa Cruz, CA) or
anti-Lck mAb (Upstate Cell Signaling, Charlottesville, VA). Membranes were washed, incubated with goat anti-mouse immunoglobulin (1:1000 dilution; Southern Biotechnology, Birmingham,
AL) conjugated to horseradish peroxidase. The Western blots
were developed using chemiluminescence (ECL; Amersham Biosciences) and analysed by digital densitometry (Kodak Image
Systems). GM1 was detected by spotting 1 µl directly on nitrocellulose membranes; samples were adjusted for phosphate content. The membranes were blocked in BLOTTO and then
incubated with CTB conjugated to horseradish peroxidase
(85 ng ml−1; Sigma Chemical) for 1 h. The membranes were
washed and analysed as described above.

Analysis of lipid composition
Cholesterol was determined as described by Allain et al. (1974)
and total phosphate as described by Bartlett (1959). Lipids were
extracted from the low-buoyant-density fractions as previously
described (Bligh and Dyer, 1959). Before the extraction of lipids
from the detergent solubilized fractions, samples were dialysed
for 48 h against 10 mM Hepes, 0.5 M NaCl, pH 7.4 to remove
detergent. The extraction yield of total phospholipid was
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90 ± 3.6% indicating that the presence of residual detergent (Triton X-100 or OG) in the solubilized fractions did not interfere with
the extraction. Chloroform extracts were evaporated under nitrogen and diluted into chloroform immediately before lipid analysis
by gradient elution using normal phase HPLC/ELSD (AvantiPolar Lipids, Alabaster, AL). Standards 1 mg ml−1 included: triolein, cholesterol, ceramide, oleic acid, phosphatidylglycerol
(PG), phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylserine (PS), phosphatidic acid (PA), soy-phosphatidylinositol (PI), and 0.5 mg ml−1 lyso-phosphatidylcholine (lysoPC), lyso-phosphatidylethanolamine (lyso-PE), lyso-phosphatidylglycerol (lyso-PG) and lyso-phosphatidylserine (lyso-PS).
Standards and samples were injected on a normal phase HPLC
column and analysed by an evaporative light scattering detector
(ELSD). A five-level calibration curve was used to calculate the
amount of lipid species in each sample.

Laser confocal microscopy
Jurkat cells were incubated (2 × 106 ml−1) with CTB conjugated
to AlexaFluor 647 (1 µg ml−1; Molecular Probes) for 30 min at
4°C; after washing twice with medium, CTB was cross-linked with
goat anti-CTB sera (1:25 dilution; Calbiochem) for 30 min at 4°C
followed by an additional 45 min incubation at 37°C. Cells were
washed and incubated with Cdt holotoxin (2 µg ml−1) for 2 h at
37°C; after two washes the cells were blocked with normal goat
IgG (Southern Biotechnology), treated with anti-Cdt mAb for
30 min at 4°C, washed, stained with goat anti-mouse Ig conjugated to biotin (1 µg; Southern Biotechnology) for 30 min at 4°C,
washed and exposed to streptavidin conjugated to FITC (0.2 µg;
Molecular Probes). The cells were then fixed in 2% paraformaldehyde, washed, permeabilized with 0.1% sodium citrate and
0.1% Triton X-100 for 2 min, washed and stained with DAPI
(0.75 µM); stained cells were centrifuged and mounted onto
microscope slides using Fluoromount-G (Southern Biotechnology). Images of cells were taken on a Bio-Rad Radiance 2100
confocal Microscope (Bio-Rad, Hercules, CA). DAPI, FITC and
AlexaFluor 647 fluorescence were excited by blue diode, argon
(488 nm) and red diode lasers respectively. Fluorescence emission was captured using the following filters: 376 ± 24 nm (DAPI);
515 ± 30 nm (FITC) and 660 nm and above (AlexaFluor 647). All
images were captured with the same laser settings. Analysis of
fluorescent probe colocalization was performed using image
analysis software (Metamorph; Universal Imaging Corporation,
Downingtown, PA). Regions of interest were defined to include
cells that did not overlap. The region was segmented to select
pixels above a constant threshold value (> 60% above background) which represent true fluorescence. As both spatial location and intensity of pixels contribute to colocalization, the values
represent the integrated intensity; pixels in both FITC and AlexaFluor 647 images had similar brightness values and spatial
location. Colocalization analysis was performed on all cells
present in Figs 2–4.

Generation of anti-Cdt mAbs
Recombinant Cdt holotoxin was expressed in E. coli using a
plasmid containing all three cdt genes (pUCAacdtABChis) as previously described; the His-tagged complex was purified by nickel

affinity chromatography (Shenker et al., 2004). Anti-Cdt mAbs
were generated as previously described (Lally et al., 1997).
Briefly, BALB/c mice (Charles River Laboratories, Wilmington,
MA) 10–12 weeks old were immunized by IP injection with 10–
20 µg Cdt holotoxin on days 0, 10, 20 and 30 and allowed to rest
for 30 days. Three days before fusion, the animals received 10 µg
of peptide intravenously. Splenocytes were fused to Sp2/0-Ag14
myeloma cells in the presence of 50% polyethylene glycol (Kodak
1450). The cells were then dispersed in Kennett’s HY medium
containing 20% FBS, glutamine, oxaloacetate, pyruvate, hypoxanthine and azaserine and fed 7 days later in medium lacking
azaserine. Clones were visible 7–9 days after fusion and were
first screened by Cdt ELISA. All mAbs were further screened by
ELISA to identify the specific subunit with which they react as
well as by immunofluorescence to determine whether the antibody was able to recognize an available epitope once the toxin
had reacted with cells. Briefly, Jurkat cells were treated with Cdt
holotoxin (2 µg ml−1) for 2 h at 37°C; cells were then washed and
treated with varying amounts of anti-Cdt mAb for 30 min After
washing the cells were first blocked with normal goat IgG (Southern Biotechnology) and exposed to goat anti-mouse Ig conjugated to biotin, washed, and treated with streptavidin-FITC
(0.2 µg; Molecular Probes) for 30 min. FITC fluorescence was
assessed by flow cytometry as previously described (Shenker
et al., 2004).
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